Treatment of T cell disorders

Details for Australian Patent Application No. 2001295270 (hide)

Owner Norwood Immunology Ltd

Inventors Boyd, Richard Lennox

Agent FB Rice

Pub. Number AU-B-2001295270

PCT Pub. Number WO02/30435

Priority PR0745 13.10.00 AU

Filing date 15 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 9 August 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/09 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

7 October 2004 Assignment before Grant

  Monash University The application has been assigned to Norwood Immunology Ltd 2002

9 August 2007 Application Accepted

  Published as AU-B-2001295270

30 August 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Aug 2007. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2002

13 December 2007 Standard Patent Sealed

10 January 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Aug 2007 2002

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001295271

2001295269